We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$3.29B
AUM Growth
+$114M
Cap. Flow
+$72.8M
Cap. Flow %
2.21%
Top 10 Hldgs %
56.45%
Holding
84
New
2
Increased
26
Reduced
32
Closed
4

Top Buys

Rank Stock Value
1
EG icon
Everest Group
EG
+$172M
2
TME icon
Tencent Music
TME
+$59.2M
3
BABA icon
Alibaba
BABA
+$52.6M
4
BIDU icon
Baidu
BIDU
+$34.7M
5
CB icon
Chubb
CB
+$21.5M

Top Sells

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$106M
2
AON icon
Aon
AON
+$46.1M
3
TCOM icon
Trip.com Group
TCOM
+$46M
4
CMCSA icon
Comcast
CMCSA
+$34.3M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22.5M

Sector Composition

Rank Sector Weight
1 Financials 29.3%
2 Communication Services 18.42%
3 Technology 11.6%
4 Consumer Discretionary 11.24%
5 Healthcare 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MORF
51
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$3.93M 0.12%
68,485
AERI
52
DELISTED
Aerie Pharmaceuticals
AERI
$3.84M 0.12%
240,000
LNTH icon
53
Lantheus
LNTH
$6.58B
$3.59M 0.11%
130,000
BKD icon
54
Brookdale Senior Living
BKD
$3.49B
$3.5M 0.11%
442,452
ICPT
55
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.37M 0.1%
168,800
XENE icon
56
Xenon Pharmaceuticals
XENE
$6.2B
$3.17M 0.1%
170,000
ELV icon
57
Elevance Health
ELV
$81.6B
$3.09M 0.09%
+8,100
New +$3.1M
JAZZ icon
58
Jazz Pharmaceuticals
JAZZ
$16.2B
$2.67M 0.08%
15,000
FATE icon
59
Fate Therapeutics
FATE
$293M
$2.6M 0.08%
30,000
SGMO
60
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.59M 0.08%
216,500
ITCI
61
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.45M 0.07%
60,000
AXGN icon
62
Axogen
AXGN
$2.2B
$2.38M 0.07%
110,000
PRQR icon
63
ProQR Therapeutics
PRQR
$251M
$2.17M 0.07%
321,360
NVST icon
64
Envista
NVST
$4.52B
$2.16M 0.07%
50,000
MMSI icon
65
Merit Medical Systems
MMSI
$4.97B
$1.89M 0.06%
29,202
-10,000
-26% -$618K
MGNX icon
66
MacroGenics
MGNX
$240M
$1.88M 0.06%
70,000
KURA icon
67
Kura Oncology
KURA
$826M
$1.88M 0.06%
90,000
+20,000
+29% +$497K
AGTC
68
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.47M 0.04%
376,900
ATRA icon
69
Atara Biotherapeutics
ATRA
$73.6M
$1.4M 0.04%
3,600
+400
+13% +$143K
JD icon
70
JD.com
JD
$43.6B
$1.22M 0.04%
15,248
-151
-1% -$11.4K
CABA icon
71
Cabaletta Bio
CABA
$444M
$1.12M 0.03%
130,000
+10,000
+8% +$98.3K
DCTH icon
72
Delcath Systems
DCTH
$416M
$1.01M 0.03%
80,000
+30,000
+60% +$344K
TS icon
73
Tenaris
TS
$28.6B
$963K 0.03%
44,005
-437
-1% -$9.88K
INFY icon
74
Infosys
INFY
$48.4B
$955K 0.03%
45,094
-20,135
-31% -$385K
VALE icon
75
Vale
VALE
$63.8B
$798K 0.02%
34,965
-347
-1% -$7.25K

Similar funds

Altrinsic Global Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Altrinsic Global Advisors held 84 positions worth $3.29B, up 3.6% from $3.17B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Altrinsic Global Advisors's Q2 2021 filing shows 2 new, 26 increased, 32 reduced and 4 closed positions. Its largest new stake was Everest Group: 659,815 shares worth $166M. The largest sale was Cognizant, an estimated $106M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 27% a quarter earlier, followed by Communication Services and Technology.

  • Altrinsic Global Advisors's largest Q2 2021 buy was Everest Group: 659,815 shares worth $166M.
  • Altrinsic Global Advisors added most to Tencent Music in Q2 2021, an estimated $59.2M increase.
  • Altrinsic Global Advisors's biggest Q2 2021 reduction was Cognizant, cutting an estimated $106M.
  • Altrinsic Global Advisors fully exited Coterra Energy in Q2 2021, selling an estimated $13.4M.
  • Altrinsic Global Advisors's ten largest holdings make up 56% of its $3.29B portfolio in Q2 2021.
  • Altrinsic Global Advisors opened 2 new positions and closed 4 in Q2 2021.
  • Altrinsic Global Advisors's portfolio value rose 3.6% quarter-over-quarter to $3.29B.

Based on Altrinsic Global Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.